Rezolute Form 4 details new director RSU and option grants

Rhea-AI Filing Summary

Rezolute, Inc. reported an equity award to a director. A board member received 21,000 common shares in the form of restricted stock units on November 19, 2025, recorded at a price of $0, increasing their directly held stake to 114,025 common shares after the transaction. These restricted stock units fully vest on December 1, 2026.

The director was also granted a stock option covering 12,000 common shares at an exercise price of $10.16 per share, expiring on November 19, 2035. The option grant also fully vests on December 1, 2026, aligning both equity awards to the same vesting date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hogenhuis Wladimir

(Last) (First) (Middle)

C/O REZOLUTE, INC.

275 SHORELINE DRIVE, SUITE 500

(Street)

REDWOOD CITY CA 94065

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Rezolute, Inc. [ RZLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/19/2025		A		21,000(1)	A	$0	114,025	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (Right to Buy)	$10.16	11/19/2025		A		12,000		(2)	11/19/2035	Common Shares	12,000	$0	12,000	D

Explanation of Responses:

1. Represents grant of restricted stock units which fully vest on December 1, 2026.

2. The options fully vest on December 1, 2026.

	/s/ Wladimir Hogenhuis	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Rezolute (RZLT) report in this Form 4?

The filing reports that a Rezolute director received an equity award consisting of 21,000 restricted stock units of common shares and a stock option for 12,000 common shares on November 19, 2025.

How many Rezolute (RZLT) restricted stock units were granted and when do they vest?

The director received 21,000 restricted stock units of Rezolute common shares. According to the filing, these units fully vest on December 1, 2026.

What are the key terms of the Rezolute (RZLT) stock options disclosed?

The director was granted a stock option for 12,000 common shares with an exercise price of $10.16 per share. The options expire on November 19, 2035 and fully vest on December 1, 2026.

What is the director’s Rezolute (RZLT) share ownership after this Form 4 transaction?

After the reported transactions, the director beneficially owns 114,025 Rezolute common shares, held in direct ownership form.

What is the relationship of the reporting person to Rezolute (RZLT)?

The reporting person is identified as a director of Rezolute, Inc., as indicated in the relationship section of the filing.

Were the Rezolute (RZLT) equity awards in this Form 4 granted for cash consideration?

The common shares and stock options are reported with a price of $0 for the acquired securities, indicating they were granted as equity compensation.